Blog Viewer

Frequent Neurologic Manifestations and Encephalopathy‐Associated Morbidity in COVID‐19 Patients

By Currents Editor posted 11-02-2020 11:51

  

Annals of Clinical and Translational Neurology (10/05/20) doi: 10.1002/acn3.51210

Liotta, Eric M.; Batra, Ayush; Clark, Jeffrey R.; et al.

https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.51210

Most hospitalized COVID-19 patients experienced neurologic symptoms at some point during the course of the disease, according to new research. The retrospective study—conducted within a hospital network in Chicago—identified neurologic manifestations at COVID-19 onset among 42.2% (215) of 509 patients, at hospitalization in 62.7% (319), and at any time during the disease in 82.3% (419). The most frequent neurologic symptoms were myalgias, headaches, encephalopathy, dizziness, dysgeusia, and anosmia. Severe COVID-19 infection and younger age were independent risk factors for developing any neurologic symptom. The researchers report that 71.1% of the patients had a favorable functional outcome at discharge. However, for encephalopathy patients, there were lower functional outcomes and an increase risk of death within 30 days of hospitalization.

#LiteratureWatch

#COVID-19

​​
FURTHER READING
The Lancet (11/14/20) Vol. 396, No. 10262, P. 1574  doi: 10.1016/S0140-6736(20)32163-2 Thomalla, Götz; Boutitie, Florent; Ma, Henry; et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32163-2/fulltext   Although stroke patients with unknown time of onset have previously ...
Neurology (11/17/20) Vol. 95, No. 20  doi: 10.1212/WNL.0000000000010738 Reznik, Michael E.; Moody, Scott; Murray, Kayleigh; et al. https://n.neurology.org/content/95/20/e2727   Researchers report an association between delirium and withdrawal of life-sustaining treatment (WLST) after intracerebral ...
By Yama Akbari MD, PhD, and Michael L. James MD, FAHA Acknowledgement: ROSC Currents Taskforce (Shraddha Mainali, MD; Jennifer Kim, MD, PhD; Ruchi Jha, MD; Tom Lawson, CNP; Minjee Kim, MD; Cassia Righy, MD, PhD; Caitlin Brown, PharmD) Translational research “moves [work] in a bidirectional manner ...